Tel:
+49 (0)241 95 163 153
Fax:
+49 (0)241 95 163 155
E-Mail:
orders@anticorps-enligne.fr

Recombinant TNFRSF8 (Brentuximab Biosimilar) anticorps

Research Grade Reactivité: Humain ELISA Hôte: Souris Chimeric unconjugated Recombinant Antibody
N° du produit ABIN6964430
  • Antigène Tous les produits TNFRSF8 (Brentuximab Biosimilar)
    TNFRSF8 (Brentuximab Biosimilar)
    Type d'anticorp
    Recombinant Antibody
    Reactivité
    Humain
    Hôte
    • 1
    Souris
    Clonalité
    • 1
    Chimeric
    Conjugué
    • 1
    Cet anticorp TNFRSF8 (Brentuximab Biosimilar) est non-conjugé
    Application
    • 1
    • 1
    ELISA
    Fonction
    Anti-CD30 (brentuximab biosimilar) mAb
    Attributs du produit
    SGN-35, cAC10-Val-Cit-MMAE
    Purification
    Purified from cell culture supernatant by affinity chromatography
    Classe de qualité
    Research Grade
    Isotype
    IgG1
  • Indications d'application
    ELISA 1:5000-10000
    Commentaires

    Research grade biosimilar. Not for use in therapeutic or diagnostic procedures for humans or animals.

    Restrictions
    For Research Use only
  • Format
    Lyophilized
    Reconstitution
    Reconstitute with deionized water
    Buffer
    Lyophilized from sterile PBS, pH 7.4. Normally 5 % - 8 % trehalose is added as protectants before lyophilization.
    Stock
    -20 °C,-80 °C
    Stockage commentaire
    Store at -20°C to -80°C for 12 months in lyophilized form. After reconstitution, if not intended for use within a month, aliquot and store at -80°C (Avoid repeated freezing and thawing). Lyophilized proteins are shipped at ambient temperature.
    Date de péremption
    12 months
  • Antigène
    TNFRSF8 (Brentuximab Biosimilar)
    Autre désignation
    CD30 (Brentuximab Biosimilar) (TNFRSF8 (Brentuximab Biosimilar) Produits)
    Classe de substances
    Biosimilar
    Sujet
    Synonyms: TNFRSF8,CD30,D1S166E,Ki-1
    UniProt
    P28908
Vous êtes ici:
Support technique